peptide
Thymosin Alpha-1
strongResearch Use OnlyInjection
28-amino-acid immune peptide from thymus tissue. Strengthens T-cell maturation, boosts natural killer cells, and balances immune response. Tested in 30+ trials, approved in 35+ countries for hepatitis, HIV support, and infections. No serious side effects.
Key facts
- Classification
- Thymosin Alpha-1 is a 28-amino acid peptide from thymic tissue.
- Primary benefits
- Immune Support (10/10) · Longevity (5/10) · Inflammation (5/10)
- Administration
- Injection
- Doses studied
- 1.6-2 mg subq once or twice a week. Standard protocol is 1.6 mg twice weekly for 6-12+ months. You can increase frequency if you're fighting off an acute illness. Consistency matters more than timing.
- Evidence strength
- Strong — 20 peer-reviewed studies
- Stacks well with
- Thymalin, BPC-157, LL-37, Selank
- Legal status
- Research Use Only · not prescribable in US
Quick stats
- Type
- Peptide
- Administration
- Injection
- Studies referenced
- 20
- Stacks with
- 5 peptides
- Regulatory
- Research Use Only
Scientific overview
Thymosin Alpha-1 is a 28-amino acid peptide from thymic tissue. Enhances T-cell maturation, dendritic cell function, and NK cell activity. Modulates TLR2/5/9 signaling and promotes Th1 responses. Approved in 35+ countries for hepatitis B/C, with data spanning 3,000+ patients in controlled trials.
Goal coverage · Thymosin Alpha-1
🛡️ Immune Support10/10
⏳ Longevity5/10
🧊 Inflammation5/10
🫃 Gut Health3/10
Medical oversight strongly recommendedNot safe during pregnancy· 3 contraindications